Cincinnati · Montgomery · Edgewood, KY By appointment · Most insurance accepted
Contact
Request a Consultation

RegenLife Centers · Physician-led care

Facet Joint Syndrome

Diagnosis and Regenerative Treatment

Published on November 4th, 2026

Caitlyn Benton
Written by
Caitlyn Benton
Dr. Zeeshan Tayeb
Reviewed and Approved by
Dr. Zeeshan Tayeb

The patient who has spent two years being told that their chronic low back pain is "muscular", who has tried three rounds of physical therapy, a course of NSAIDs, and a steroid injection that helped for three weeks before the pain returned, rarely knows that the joints responsible for their symptoms are among the most anatomically precise targets for regenerative injection in the spine, or that the diagnosis confirming them as the source requires a specific interventional protocol that most primary care pathways never order. The 55-year-old who wakes stiff every morning, who finds that leaning backward aggravates a deep, aching pain through the lower back and into the buttock, who has been handed an MRI report noting "mild degenerative changes" and sent home with muscle relaxants: this patient almost certainly has a facet-mediated pain syndrome that standard imaging cannot confirm and standard prescriptions cannot resolve.

Facet joint syndrome diagnosis and regenerative treatment at RegenLife Centers for Integrative Pain & Weight Management begins from a clinically distinct premise: that lumbar facet joints account for 15–45% of chronic low back pain and cervical facet joints contribute to 39–67% of chronic neck pain, making zygapophyseal joint arthropathy one of the most prevalent and consistently under-diagnosed drivers of spinal pain in adults, and that the patients most likely to benefit from regenerative treatment are precisely those who have cycled through the standard management pathway without anyone confirming which structure is generating their pain, or offering the biological repair options that current evidence supports.

A man with a large tattoo on his back holds his lower back outdoors, showing discomfort.A man with a large tattoo on his back holds his lower back outdoors, showing discomfort.

Key Takeaways

  • Facet joints are the only true synovial joints in the spine and account for 15–45% of lumbar chronic back pain and 39–67% of cervical chronic neck pain: yet imaging findings alone cannot confirm a facet pain diagnosis, and most patients cycle through standard care without ever receiving the diagnostic medial branch block that identifies the source
  • PRP injection into lumbar facet joints produces significant, long-term pain reduction and disability improvement for at least one year in CT-guided studies; in cervical facet pain from whiplash, 53% of patients exceeded the minimal clinically important difference for pain at 12 months with a mean improvement of 66%
  • Corticosteroid facet injections carry a quality of evidence rated "very low" by GRADE methodology, with sham-controlled trials showing no efficacy compared to saline: establishing regenerative approaches as biologically superior to the standard injection that most patients receive
  • Radiofrequency ablation of the medial branch nerves produces 6–24 months of pain relief for confirmed facet joint pain, and is most appropriate as a bridge or complement to regenerative treatment rather than a substitute for addressing the underlying joint degeneration

Understanding Facet Joint Anatomy and Why These Joints Fail

The Only True Synovial Joints in the Spine

The facet joints, also called zygapophyseal joints or Z-joints, are the only true synovial joints in the spine, formed at each vertebral level by the articulation of the inferior articular process of one vertebra with the superior articular process of the vertebra below. Like all synovial joints, they are enclosed by a fibrous capsule lined with synovial membrane, lubricated by synovial fluid, and cushioned by hyaline cartilage on the articulating surfaces. The joint capsule contains mechanoreceptors and nociceptors innervated by the medial branches of the dorsal rami, a dual sensory role that makes the facet joint both a position sensor for proprioceptive feedback and a pain generator when those capsular receptors are stimulated by inflammation, instability, or cartilage loss.

Biomechanically, the facet joints perform a critical function: they guide spinal segmental motion, allowing flexion, extension, and rotation within defined ranges, while resisting the translational shear and excessive rotation that would otherwise destabilize the motion segment and compress the neural elements occupying the adjacent foramen. The L4-L5 and L5-S1 facet joints bear the greatest mechanical loads in the lumbar spine, which explains why these levels generate the highest proportion of lumbar facet pain. In the cervical spine, C5-C6 and C2-C3 are the most commonly affected levels, with C2-C3 facet pathology contributing disproportionately to cervicogenic headache through the convergent nociceptive input it shares with the trigeminal nucleus.

How Facet Joints Degenerate

The degenerative process in facet joints begins with articular cartilage deterioration, the same osteoarthritic cascade that affects peripheral synovial joints, driven by mechanical loading, inflammatory cytokines, and the cumulative effect of repetitive microtrauma. As cartilage thins, the synovial membrane thickens and produces increasingly viscous, less lubricating synovial fluid; the resultant increase in friction accelerates subchondral bone exposure and stimulates periarticular bone spur formation that can impinge on adjacent structures including the neural foramen. Osteoarthritis of the facet joints is effectively universal in adults over 60 years of age, but the presence of structural degeneration on imaging does not predict whether the joint is generating pain, which is the diagnostic challenge that the standard management pathway fails to resolve.

The inflammatory component of facet joint degeneration is clinically important: elevated concentrations of TNF-α, IL-1β, and other pro-inflammatory mediators in the facet joint capsule and synovium amplify the nociceptive input from an already mechanically stressed joint, creating a biochemical pain environment that pharmacological anti-inflammation only partially addresses. This inflammatory-biological dimension is precisely the domain that regenerative treatment approaches directly, rather than suppressing symptoms while the joint environment continues its catabolic trajectory.

Who Develops Facet Joint Syndrome

Facet joint syndrome affects a broad demographic, but its incidence increases markedly with age: prevalence rises from approximately 18% in the 31–40 age group to 44% in the 51–60 cohort, with rates continuing to climb through the seventh decade. Beyond age, the risk profile includes prior spinal trauma, including motor vehicle accidents, which disproportionately load the cervical facet joints and account for a large proportion of whiplash-associated facet pain, repetitive occupational loading in flexion and rotation, prior spinal surgery (where adjacent-level facet loading increases as the fused segment transfers its motion demands), and the systemic metabolic contributors, diabetes, obesity, and systemic inflammation, that accelerate articular cartilage degradation at every synovial joint in the body.


Why Facet Joint Syndrome Is So Often Misdiagnosed

Pain Patterns That Mimic Other Conditions

The referred pain patterns of facet joint arthropathy are predictable by spinal level but are not dermatomal. They do not follow the nerve root distributions that guide radiculopathy diagnosis, and they are frequently mistaken for disc herniation, sacroiliac joint dysfunction, hip pathology, or nonspecific muscle strain depending on where in the referral zone symptoms concentrate. Lumbar facet pain from L4-L5 and L5-S1 typically refers into the buttock and posterior thigh, often interpreted as sciatica, but facet-mediated pseudoradicular pain characteristically ends above the knee, without the neurological deficits of dermatomal sensory loss, motor weakness, or diminished reflexes that true radiculopathy produces. Cervical facet pain from C2-C3 produces occipital headache that mimics tension-type or migraine headache; C5-C6 involvement produces shoulder and upper arm pain indistinguishable on history from rotator cuff pathology.

The temporal pattern is characteristic and clinically useful: facet pain is typically worse in the morning, reflecting the overnight accumulation of synovial joint stiffness, and worsens with spinal extension and rotation while improving with forward flexion, which opens the facet joint space and reduces capsular load. This extension-loading pattern contrasts with discogenic pain, which typically worsens with flexion and prolonged sitting.

The Imaging Trap

The most clinically damaging misconception in facet joint syndrome management is the belief that imaging can confirm the diagnosis. MRI and CT reliably demonstrate structural facet joint degeneration, joint space narrowing, subchondral sclerosis, osteophyte formation, synovial cyst development, and periarticular inflammation, but multiple studies have established that imaging findings do not predict which joints are symptomatic. A patient with severe bilateral facet arthropathy on MRI may have pain driven by adjacent disc pathology, while a patient with only mild imaging changes at L5-S1 may have that level generating most of their symptoms. The structural finding and the pain source are independent diagnoses requiring independent confirmation, and the standard referral pathway that returns patients to primary care with an MRI report reading "multilevel degenerative changes" has made no diagnostic progress toward identifying the pain generator.

When Physical Examination Falls Short

Examination findings for facet joint syndrome, localized paravertebral tenderness, reproduction of pain with the Kemp test (lumbar extension and ipsilateral rotation), and the absence of neurological deficits, have clinical value in raising diagnostic suspicion but have insufficient specificity to confirm or exclude facet-mediated pain as the diagnosis. Physical and neurological examination cannot reliably identify symptomatic facet joints as the pain source, according to the evidence base for interventional spine medicine. Clinical presentation narrows the differential and directs the diagnostic workup, but the confirmatory step requires a targeted interventional procedure.


Diagnosing Facet Joint Pain: The Medial Branch Block Protocol

A physician reviews a spinal imaging study, identifying structural pathology to guide targeted diagnosis and treatmentA physician reviews a spinal imaging study, identifying structural pathology to guide targeted diagnosis and treatment

The Medial Branch Block: Diagnostic Gold Standard

The diagnostic medial branch block is the established gold standard for confirming facet joint pain as the source of spinal symptoms. The medial branches of the dorsal rami are the sensory nerves supplying each facet joint capsule; blocking these nerves with local anesthetic, under fluoroscopic or CT guidance at the anatomically defined medial branch points for the suspected levels, temporarily silences the pain signal from the joint. A positive response, defined as significant and reproducible pain relief following the block, confirms that the blocked facet level is generating the patient's symptoms.

The diagnostic protocol requires two separate medial branch blocks at two or more spinal levels on two separate occasions, the dual-block protocol that controls for the false-positive rate inherent in single-block assessment. This rigorous confirmation is the foundation for appropriate treatment selection: only patients with confirmed facet-mediated pain on a properly conducted dual medial branch block protocol are candidates for the definitive interventions that provide sustained relief. The patient who has received a single intra-articular facet injection as both diagnosis and treatment has not been evaluated by the confirmatory standard that the literature supports.

Intra-Articular Injection as a Diagnostic and Therapeutic Tool

Intra-articular injection of local anesthetic directly into the facet joint, rather than at the medial branch nerves, can also serve as a diagnostic test and provides simultaneous short-term therapeutic benefit. The diagnostic value is slightly less specific than medial branch blocks because joint capsule distension and local anesthetic spread to adjacent structures can produce partial pain relief from non-facet sources; however, for patients in whom the medial branch block protocol is combined with intra-articular regenerative injection, the diagnostic and therapeutic procedures can be efficiently integrated into the same image-guided session.

Kemp's Test and Clinical Examination

While examination cannot confirm the diagnosis, the Kemp test, asking the patient to extend the lumbar spine and rotate toward the symptomatic side while the examiner applies gentle overpressure, is clinically useful when positive: reproduction of the patient's familiar posterior thigh or buttock pain (rather than sharp radicular leg pain) increases the pretest probability of facet joint involvement and directs the workup toward medial branch evaluation. The diagnostic services at RegenLife integrate clinical examination findings with imaging review and the confirmatory medial branch block protocol to arrive at a precise anatomic diagnosis before any treatment decision is made.


PRP Therapy for Facet Joint Syndrome: Biological Repair at the Joint Level

A clinician prepares a targeted injection in a clinical setting, delivering regenerative therapy to a patient's spinal jointA clinician prepares a targeted injection in a clinical setting, delivering regenerative therapy to a patient's spinal joint

How PRP Addresses Facet Joint Degeneration

PRP therapy concentrates the patient's own platelets to 3–8 times their baseline blood concentration, delivering a payload of platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) directly into the facet joint via intra-articular injection under image guidance. These growth factors are the biological signals that drive synovial membrane repair, articular cartilage matrix remodeling, and the reduction of the pro-inflammatory cytokine environment that amplifies facet joint nociception. The mechanism is both anti-inflammatory and regenerative: PRP modulates the TNF-α and IL-1β concentrations that drive the catabolic joint environment, while simultaneously delivering the anabolic signals that support the chondrocyte and fibroblast activity responsible for cartilage and capsular matrix restoration.

For a joint whose degeneration is driven by the combination of mechanical loading, articular cartilage loss, and synovial inflammation, PRP addresses all three biological dimensions simultaneously, a meaningful contrast with corticosteroid injection, which suppresses inflammation transiently while providing no biological support for the repair of the articular and capsular structures the inflammation is destroying.

What the Clinical Evidence Shows

The clinical evidence for PRP in facet joint syndrome, while earlier in development than the PRP literature for peripheral joints, demonstrates consistent and clinically meaningful benefit across both lumbar and cervical presentations. CT-guided PRP injection for lumbar facet joint syndrome produces significant, long-term reductions in pain scores and disability indices sustained for at least one year in prospective clinical data, outcomes that corticosteroid injection, with its established short-term efficacy and very-low-quality long-term evidence base, does not consistently replicate at that duration.

For cervical facet pain, particularly the whiplash-associated cervical facet arthropathy that motor vehicle accidents generate, the outcomes data is particularly compelling: at 12-month follow-up, 53% of patients treated with PRP exceeded the minimal clinically important difference for pain, with a mean pain improvement of 66%. Disability outcomes were similarly robust, with 69% of patients exceeding the MCID for functional measures and a mean improvement of 48%. These are durable outcomes in a patient population, post-whiplash cervical facet pain, that standard injection therapy manages poorly and that radiofrequency ablation addresses only temporarily without modifying the underlying joint pathology.

The contrast with corticosteroid injection is clinically important: while steroid injections achieve reported success rates of 13–74% at one month across heterogeneous study populations, rigorous sham-controlled trials demonstrate no statistically or clinically significant difference between corticosteroid and saline injection for facet joint pain, and the overall quality of evidence for corticosteroid facet injection is rated "very low" by GRADE methodology due to high risk of bias and outcome heterogeneity. PRP's mechanism, delivering biological repair signals rather than pharmacological inflammation suppression, is matched to the long-term treatment objective in a way that corticosteroids are not.

Patient Selection for PRP in Facet Joint Syndrome

The patients most likely to achieve durable benefit from intra-articular PRP are those with confirmed facet-mediated pain on medial branch block protocol, mild-to-moderate structural degeneration on imaging where cartilaginous and capsular repair capacity has not been exhausted by end-stage joint destruction, and those whose corticosteroid injection response, if they received one, was short-lived, suggesting that inflammation suppression alone is insufficient and that biological repair support is the missing element. Patients with systemic metabolic conditions that impair growth factor receptor signaling, particularly uncontrolled diabetes and systemic inflammatory conditions, achieve meaningfully better outcomes when those contributors are addressed concurrently with regenerative injection. The lifestyle medicine and hormone therapy components of the RegenLife protocol evaluate and manage these systemic determinants of regenerative response as an integrated part of the treatment plan.


Prolotherapy and Interventional Procedures for Facet-Mediated Pain

The Fibroblastic Case for Periarticular Prolotherapy

Prolotherapy applied to facet joint syndrome uses perineural and periarticular injection of concentrated dextrose solution to initiate the fibroblastic repair response in the joint capsule and surrounding spinal ligamentous structures that contribute to segmental instability and abnormal loading of the facet joint surfaces. The biological rationale for combining prolotherapy with intra-articular PRP is grounded in the same structural principle that applies across complex joint injuries: the facet joint is not an isolated structure. It operates within a spinal motion segment whose stability depends on the integrity of the intervertebral disc, the anterior and posterior longitudinal ligaments, the ligamentum flavum, and the interspinous ligamentous complex, and when any of these contributors to segmental stability is lax or degenerated, the facet joint bears abnormal translational and rotational loads that accelerate its articular degeneration regardless of how precisely the joint itself is treated.

Periarticular dextrose prolotherapy directed at the facet joint capsule and the adjacent ligamentous attachments restores the passive stability envelope in which the facet joint operates, reducing the abnormal mechanical loading that perpetuates cartilage degradation and capsular inflammation. For patients with combined facet arthropathy and ligamentous laxity, a pattern common in hypermobile patients, post-traumatic presentations, and those with multi-level degenerative spinal disease, the combination of intra-articular PRP and periarticular prolotherapy addresses both the joint-level biological environment and the mechanical-stability environment in which the joint must function.

Medial Branch Blocks and Radiofrequency Ablation

For patients with confirmed facet-mediated pain who require more immediate and sustained pain relief as the regenerative repair process consolidates, medial branch radiofrequency ablation (RFA) provides a complementary interventional pathway. Following positive dual medial branch blocks confirming the symptomatic level, RFA applies thermal energy to the medial branch nerves, disrupting their ability to transmit facet joint pain signals for an extended period. Medial branch RFA produces 6–24 months of meaningful pain relief for confirmed facet joint pain, a duration that gives the biological environment time for regenerative repair to progress while the patient is not limited by active joint-generated pain during rehabilitation.

The appropriate framing for RFA within the facet joint syndrome treatment sequence is as a functional bridge, not a substitute for biological repair. RFA addresses the pain signal without modifying the joint pathology generating it: the facet joint continues its degenerative trajectory, the medial branch nerve regenerates over 12–24 months, and the pain returns when the nerve restores its function. Combining RFA-delivered pain relief with PRP-initiated biological repair creates a treatment window in which the patient can engage with rehabilitative therapy under reduced pain burden while the joint environment moves toward structural restoration. The interventional procedures team at RegenLife sequences these modalities based on diagnostic findings and patient-specific presentations.


Conservative and Rehabilitative Care for Facet Joint Syndrome

A physical therapist provides hands-on rehabilitation for a patient with chronic spinal pain, supporting neuromuscular recoveryA physical therapist provides hands-on rehabilitation for a patient with chronic spinal pain, supporting neuromuscular recovery

Physical Therapy for Spinal Stabilization

Physical therapy for facet joint syndrome addresses the functional deficits that spinal joint degeneration reliably produces: reduced segmental mobility, inhibited deep stabilizing musculature, altered movement patterns that increase extension-loading on already compromised facet joints, and the proximal chain biomechanical contributors, hip extension deficits, lumbar-pelvic rhythm dysfunction, that shift mechanical demand toward the spinal motion segments rather than distributing it through the kinematic chain as healthy movement patterns do.

The rehabilitative targets for lumbar facet syndrome are trunk stabilization, particularly deep multifidus activation, which provides direct segmental support to the lumbar vertebrae and reduces the dynamic loading on facet joint surfaces, and hip mobility restoration, which reduces the compensatory lumbar extension that aggravates posterior element loading. For cervical facet syndrome, cervico-scapulothoracic strengthening and endurance training address the postural contributors, forward head position, reduced thoracic extension, that increase compressive loading on posterior cervical structures. Nerve gliding and manual therapy targeting segmental mobility help restore the facet joint's normal arthrokinematic function, reducing the aberrant loading that inflamed and degenerated joint surfaces generate in restricted motion segments.

Activity Modification and Spinal Ergonomics

The patient who continues loading their lumbar spine in sustained extension, through occupational postures, recreational activities, or sleep positions that maintain the lumbar spine in a lordotic arc, is asking their facet joints to recover in the mechanical environment that generated their degeneration. Activity modification during the regenerative treatment window is not passive rest; it is directed protection of the biological repair process occurring at the joint level, analogous to the protected loading protocols that govern ligament and tendon repair following regenerative injection. Exercise therapy at RegenLife develops the individualized loading progression that transitions from protected movement in the early post-injection period to the full functional activity restoration that successful facet joint syndrome treatment should achieve.


When Surgery Is the Right Answer for Facet Joint Syndrome

Precise Surgical Indications for Facet Pathology

Surgical intervention for facet joint syndrome is the appropriate pathway in a narrow and precisely defined patient population: those with grade I or II spondylolisthesis producing symptomatic nerve compression that conservative and interventional care cannot adequately manage, patients with fractures or displacements of the facet joint complex producing structural instability, those with bone spur formation that is actively impinging neural elements confirmed on imaging and examination, and the rare patient who has genuinely failed comprehensive non-surgical management, including regenerative injection, medial branch RFA, and structured rehabilitation, after a minimum of 3–6 months.

The surgical procedures for facet-related pathology include facetectomy (trimming of the articular process to decompress adjacent neural elements) and spinal fusion when the facet pathology is accompanied by the segmental instability that facetectomy alone would amplify. Both carry meaningful trade-offs: facetectomy increases segmental instability by reducing the articular contact that the facet joint normally provides; fusion eliminates facet-generated pain at the fused level at the cost of permanently increased loading at adjacent levels, accelerating the degeneration that produces adjacent segment disease over the following decade.

Understanding What Surgery Does Not Fix

Spinal fusion for facet joint syndrome resolves the structural pain generator at the treated level but does not address the systemic degenerative process, metabolic contributors, or biomechanical loading patterns that produced the facet arthropathy in the first place. The patient who undergoes L4-L5 fusion without optimizing their metabolic health, correcting their movement patterns, and restoring their segmental mobility above and below the fusion level has addressed one painful joint while creating the conditions for accelerated degeneration at the levels adjacent to the fusion. This is the mechanistic explanation for the well-documented phenomenon of adjacent segment disease, and it is one of the strongest arguments for exhausting the biological repair options between the standard conservative pathway and the operating room before surgical reconstruction becomes the only remaining option.


The Integrated Evaluation at RegenLife: Facet Joint Syndrome Cincinnati OH

Effective diagnosis and treatment of facet-mediated spinal pain begins with an evaluation that goes beyond MRI review and symptom characterization to confirm the pain source through a targeted interventional protocol. The diagnostic services at RegenLife assess clinical presentation against imaging findings, identify the spinal levels most likely to be generating symptoms based on pain pattern mapping and examination, and coordinate the medial branch block protocol that provides the diagnostic confirmation on which treatment decisions should be based. Patients who have been managing chronic back or neck pain without ever receiving this confirmatory diagnostic step are being treated presumptively, and the regenerative treatment that follows a confirmed diagnosis is a meaningfully more precise and effective intervention than one applied without knowing which structures are generating symptoms.

The evaluation also characterizes the systemic factors that independently determine regenerative treatment response. Insulin resistance impairs growth factor receptor signaling in chondrocytes and synovial fibroblasts, reducing the biological effect of PRP regardless of injection precision or platelet concentration. Elevated systemic inflammation, reflected in CRP and inflammatory cytokine profiles, drives the joint environment toward continued catabolic breakdown even when targeted regenerative injection is delivering anabolic signals locally. Testosterone deficiency, growth hormone insufficiency, and estrogen decline all reduce the anabolic signaling capacity that articular cartilage and capsular tissue repair requires. The hormone therapy protocol at RegenLife addresses these systemic contributors directly, because the patient with unoptimized metabolic and hormonal health is a fundamentally different biological environment for regenerative treatment than one whose systemic anabolic capacity matches the repair demand the degenerated joint imposes.

The treatment sequence, confirmed diagnosis via medial branch block, intra-articular PRP for the facet joint, periarticular prolotherapy for capsular and ligamentous contributors when indicated, medial branch RFA for near-term functional relief when pain burden limits rehabilitation engagement, and structured physical therapy addressing stabilization and movement, is selected and ordered based on diagnostic findings rather than applied uniformly. Patients whose facet joint syndrome coexists with adjacent disc pathology, sacroiliac joint dysfunction, or spinal stenosis receive an integrated evaluation that identifies all structural contributors to their presentation. Additional context on related spinal conditions is available in our post on degenerative disc disease non-surgical treatment options in Cincinnati, OH and spinal stenosis treatment in Cincinnati, OH. The goal is not a single injection into a joint that has been generating pain for two years: it is a comprehensive biological and mechanical restoration that returns the patient to the functional capacity that facet joint arthropathy has progressively limited.


Contact RegenLife Centers to schedule an evaluation or ask which service fits your needs.


Frequently Asked Questions

Find answers to common questions

Ready to Learn More?

To learn more and to find out if you might be a good candidate at RegenLife, schedule a consultation with our team today.

About the Author

Caitlyn Benton

Caitlyn Benton, Research Manager at RegenLife

As Research Manager, Caitlyn Benton oversees the strategic planning and execution of clinical research projects, ensuring all studies adhere to the highest regulatory and ethical standards. With expertise in protocol development and data monitoring, she coordinates multidisciplinary teams to ensure the integrity of our clinical research programs and the accuracy of the insights shared with our patients.

Reviewed and Approved by

Dr. Zeeshan Tayeb

Dr. Zeeshan Tayeb, Medical Director at RegenLife

Interventional Spine, Pain, and Sports Medicine Dr. Zeeshan Tayeb, MD is board-certified in Pain Medicine and Physical Medicine & Rehabilitation, with specialized fellowship training in interventional spine, pain, and sports medicine. He sees patients at Pain Specialists of Cincinnati/RegenLife in Cincinnati, Ohio. Dr. Tayeb's background in physical medicine and rehabilitation has provided the foundation for his comprehensive approach to treating the whole person. Dr. Tayeb has done extensive training and education in both functional and regenerative medicine and specializes in state-of-the-art treatments, including laser therapies, PRP and stem-cell injections, and nutritional and hormonal optimization.

Disclaimer:

As a service to our readers, RegenLife provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Stay Updated With Our Latest News

Check back regularly for new articles and updates about pain management treatments, practice news, and health tips from our team of specialists.

Get In Touch

Same-week consults. Real follow-through.

Tell us what's going on. A coordinator will follow up during office hours to help book your visit.

Request a consultation

Choose the clinic that works for you.

Most new patients can be seen within the same week.

Cincinnati

3328 Westbourne Dr

Cincinnati, OH 45248

(513) 922-2204

Edgewood

162 Barnwood Dr

Edgewood, KY 41017

(859) 331-4159

Montgomery

9989 Montgomery Rd

Montgomery, OH 45242

(513) 922-2204

We accept most major insurance plans

Request